Table 1

Characteristics of units submitting data

				Pre-endoscopy actions		Stratified use* of
Site	Centre type	Annual procedure count (pre-covid)	Cases submitted	NP swab?	Mandatory self-isolation for patients (≥7 days)?	PPE	IPCPs
A	T	20 000	198	Yes	Yes	Yes	Yes
B	T	17 000	111	No	No	Yes	Yes
C	L	20 000	436	No	No	Yes	Yes
D	L	9800	365	Yes	No†	No	No
E	T	15 000	374	Yes	No	Yes	Yes
F	L	7500	58	Yes	No	No	No
G	L	9800	206	Yes	No	Yes	Yes
H	T	17 000	218	Yes	No†	Yes	Yes
I	L	15 200	351	Yes	No	Yes	Yes
J	L	17 400	175	Yes	Yes	Yes	Yes
K	T	15 000	84	Yes	No	No	No
L	T	15 600	950	No	No	Yes	Yes
M	T	20 000	363	Yes	No	Yes	Yes
N	T	30 525	219	Yes	No	No	No
O	T	15 000	715	No	No	No	No
P	L	24 000	672	No	No	No	No
Q	T	14 000	660	No	No	Yes	Yes
R	L	20 000	251	Yes	No†	Yes	Yes
Total	10T; 8 L	302 825	6208	12Y	16N	12Y	12Y

*Stratified use refers to the differential use of ‘low-risk’ and ‘high-risk’ principles according to upper vs lower GI endoscopy and COVID19-confirmed vs COVID19-excluded patients (ie, a COVID-minimised pathway as explained in references 4, 5 and 11).
†Sites suggested, but did not mandate, self-isolation of patients for 7 days preprocedure.
IPCPs, infection prevention and control policies; L, local; NP, nasopharyngeal; PPE, personal protective equipment; T, tertiary.